MedPath

乐普药业科技有限公司

Ownership
-
Established
2012-12-04
Employees
-
Market Cap
-
Website
http://www.meihuazhiyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

NMPA:7

Drug Approvals

Lenvatinib Mesilate Capsules

Product Name
甲磺酸仑伐替尼胶囊
Approval Number
国药准字H20247188
Approval Date
Aug 9, 2024
NMPA

Roxithromycin Granules

Product Name
罗红霉素颗粒
Approval Number
国药准字H20083472
Approval Date
Aug 29, 2023
NMPA

Roxithromycin Granules

Product Name
罗红霉素颗粒
Approval Number
国药准字H20083471
Approval Date
May 8, 2023
NMPA

Lenvatinib Mesilate Capsules

Product Name
甲磺酸仑伐替尼胶囊
Approval Number
国药准字H20233297
Approval Date
Mar 21, 2023
NMPA

Losartan Potassium and Hydrochlorothiazide Tablets

Product Name
氯沙坦钾氢氯噻嗪片
Approval Number
国药准字H20123367
Approval Date
Jul 18, 2022
NMPA

Losartan Potassium and Hydrochlorothiazide Tablets

Product Name
氯沙坦钾氢氯噻嗪片
Approval Number
国药准字H20217082
Approval Date
Jul 18, 2022
NMPA

Naproxen Capsules

Product Name
萘普生胶囊
Approval Number
国药准字H41023432
Approval Date
Nov 17, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.